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Incursions of classical swine fever (CSF) into disease-
 regions has signiﬁcant consequences, resulting in ban
international trade and costly control measures
ennig, 2000). Spread of CSF virus (CSFV) occurs via
ct contact between pigs, via indirect contact with
virus-contaminated fomites or via ingestion of products
from infected pigs. The oral route, via swill feeding, has
been responsible for primary disease introductions (Frit-
zemeier et al., 2000; Paton and Greiser-Wilke, 2003) and
although currently banned in the EU, the practice
continues in many parts of the world, both with and
without mandatory cooking and the possibility of illegal
activities cannot be ruled out.
Factors that affect whether or not a pig becomes
infected upon ingestion of infected pork-derived material
are important for assessing the risks that pork products
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A B S T R A C T
Outbreaks of classical swine fever are often associated with ingestion of pig meat or
products derived from infected pigs. Assessment of the disease risks associated with
material of porcine origin requires knowledge on the likely amount of virus in the original
material, how long the virus may remain viable within the resulting product and how
much of that product would need to be ingested to result in infection. Using material from
pigs infected with CSFV, we determined the viable virus concentrations in tissues that
comprise the majority of pork products. Decimal reduction values (D values), the time
required to reduce the viable virus load by 90% (or 1 log10), were determined at
temperatures of relevance for chilling, cooking, composting and ambient storage. The rate
of CSFV inactivation varied in different tissues. At lower temperatures, virus remained
viable for substantially longer in muscle and serum compared to lymphoid and fat tissues.
To enable estimation of the temperature dependence of inactivation, the temperature
change required to change the D values by 90% (Z values) were determined as 13 8C, 14 8C,
12 8C and 10 8C for lymph node, fat, muscle and serum, respectively. The amount of virus
required to infect 50% of pigs by ingestion was determined by feeding groups of animals
with moderately and highly virulent CSFV. Interestingly, the virulent virus did not initiate
infection at a lower dose than the moderately virulent strain. Although higher than for
intranasal inoculation, the amount of virus required for infection via ingestion is present in
only a few grams of tissue from infected animals.
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L. Cowan et al. / Veterinary Microbiology 176 (2015) 1–92may have for introduction and spread of CSFV (Farez and
Morley, 1997). These factors include; the likely level of
viral contamination within a product, how long the
pathogen may survive within the product under the
conditions to which it is exposed, what is the likelihood
that a susceptible animal will ingest a contaminated
product and, ﬁnally, how much product needs to be
ingested to instigate an infection (Wooldridge et al., 2006).
The level of viable virus in CSFV infected animals, and
hence the level of contamination of a product derived from
an infected animal, varies according to the virulence of the
infecting virus and the stage and course of disease
(Weesendorp et al., 2009b). The tissue tropism of the
virus will also affect the viral load found in different pork
products. The main target cells for CSFV are leukocytes,
myeloid, epithelial and endothelial cells and high con-
centrations of CSFV are found in lymphoid tissue, spleen
and blood (Belak et al., 2008; Liu et al., 2011; Weesendorp
et al., 2010). Few studies have quantiﬁed viable CSFV in
muscle and fat which constitute the major proportion of
pork products. Available data indicates the levels in muscle
and fat are low, and are often either undetectable or at the
limit of detection (Mebus et al., 1997; Thur and Hofmann,
1998), although levels as high as 104.9 TCID50/g have been
reported (Wood et al., 1988).
After slaughter, pork tissues are subjected to various
processes such as chilling of carcases, butchery, transport
and cooled storage. Products, which may or may not be
cured and/or cooked prior to generation of waste, will
then be subjected to varying conditions depending on
whatever route leads to subsequent ingestion by a
susceptible animal, such as landﬁll, composting or storage
of scraps prior to illegal swill feeding (Gale, 2004;
Wooldridge et al., 2006). Temperature, pH, the tissue
matrix and processing will affect the rate at which virus
viability decays (Depner et al., 1992; Edwards, 2000;
Farez and Morley, 1997). Studies have demonstrated the
times at which virus can no longer be detected in tissues
held at different temperatures (Edwards, 2000) and
survival kinetics in media (Depner et al., 1992), slurry
(Botner and Belsham, 2012), faeces, urine (Weesendorp
et al., 2008) and diagnostic tissues (Weesendorp et al.,
2010). However, there is a paucity of data on the rate of
thermal inactivation of CSFV in tissues that comprise pork
products.
Assessment of the risks associated with processes
which may result in the ingestion of pork products by pigs
requires knowledge of the oral infective dose. A review by
Farez and Morley (1997) highlighted that experimental
inoculation of pigs with less than 10 TCID50 CSFV could
initiate infection in a proportion of pigs (Dahle and Liess,
1995; Farez and Morley, 1997). These studies used
intranasal inoculation and thus the virus was likely to
have had direct contact with the tonsils, the primary site of
CSFV replication. The situation is very different when a pig
ingests a potentially CSFV – contaminated pork product,
where the degree of mastication and rapidity of swallow-
ing will inﬂuence if the virus can gain entry by contact with
the tonsils or via oral abrasions (Farez and Morley, 1997). It
is therefore expected that the oral pig infective dose via
ingestion will be higher than 10 TCID50.
To improve assessment of the risk of pork products for
the introduction and spread of CSF we have determined the
rate of CSFV inactivation in tissues found in pork products
and gained a more accurate estimate of the pig oral
infective dose.
2. Materials and methods
2.1. Viruses and cells
PK15 cells were propagated in EMEM with 10% v/v
Foetal Bovine Serum (FBS) and penicillin, streptomycin and
Nystatin supplement. CSFV strain UK2000/7.1 (Genotype
2.1) was isolated in the UK, the CBR/93 strain (Genotype
3.3) was kindly provided by Dr. S. Parchariyanon, National
Institute of Animal Health, Bangkok and the Brescia strain
(Genotype 1.1) was kindly provided by Dr. Alexandra
Meindl-Bo¨hmer, University of Veterinary Medicine, Hann-
over.
2.2. Tissues
Viral loads and rates of CSFV inactivation were
determined in muscle (longissimus dorsi or bicep fer-
moris), lymph node (mandibular, Ileocecal, retropharyn-
geal, ventral superﬁcial cervical), fat and serum samples
which had been stored at 80 8C after harvest from
animals experimentally infected with CSFV CBR/93,
UK2000/7.1 or Brescia, for other purposes, as described
below or previously (Everett et al., 2010; Graham et al.,
2012). Material from pigs exhibiting the acute form of CSF,
between 7 and 21 days post infection (dpi), were used for
the study.
2.3. Methods of quantitation of virus
Viable virus in tissues and oral dose inocula was
quantiﬁed by titration on PK15 cells. Samples were serially
diluted (1 in 2, 1 in 3, 1 in 5 or 1 in 10 depending on the viral
load present in the sample) in EMEM with 10% (v/v) FBS
and antibiotics and 50 ml of each dilution added to 8 wells
of a 96 well plate. Plates were incubated for 4–5 days at
37 8C with 5% CO2 prior to ﬁxing with 4% (v/v) parafor-
maldehyde and detection of virus by a modiﬁed immu-
noperoxidase staining method (Anonymous, 2012). Brieﬂy
after washing with PBS cells were incubated with 3% (v/v)
H2O2 in methanol for 10 min and permabilised with 1% (v/
v) Tween 20, 10% (v/v) normal goat serum in PBS. Virus was
detected using CSF-speciﬁc Mab WH303 or WH304
(AHVLA), rabbit anti-mouse HRP-conjugated secondary
antibody (DAKO) and 3,30-diaminobenzidine tetrahy-
drochloride (DAB) chromogenic substrate (Sigma).
2.4. Decimal reduction values of CSFV in porcine tissues,
serum and cell cultures
Thawed tissues were cut into approximately 2 mm3
sections and sections mixed to ensure homogeneity.
Aliquots of serum, cell culture medium, or sectioned
tissue (250 mg) were incubated in micro-centrifuge tubes,
at 25 8C, 56 8C or 68 8C in a circulating water bath or at 4 8C
in a
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L. Cowan et al. / Veterinary Microbiology 176 (2015) 1–9 3 refrigerator. For tissues held at 4 8C, 1 ml of PBS plus
ibiotic supplement (Mycostatin/Nystatin (500 U/ml),
ptomycin 2.5 mg/ml, polymyxinB sulphate (100 U/ml),
zyl Pencillin (100 U/ml), and Neomycin sulphate
 mg/ml)) was added to prevent microbial growth. To
pare thermostability of the three different strains, for
ich tissues from experimentally infected animals was
ilable, cell culture stocks of virus were incubated at
8C in EMEM with 10% v/v FBS plus antibiotics. In all
es, triplicate aliquots were removed at each of eight
e points and tissues homogenised with 1 ml of PBS
plemented with antibiotics in a Precellys 24 homo-
iser and 2.8 mm ceramic zirconium oxide beads
cellys CK28-R), using two, 10-s pulses at 6000 rpm
arated by a 15-s pause. After clariﬁcation of homo-
ates by centrifugation at 1000  g for 10 min at 4 8C,
ble virus was quantiﬁed by titration as above on PK15
s. Due to cell toxicity observed with muscle homo-
ates, media was replenished after 24 h. Infection was
ected by immunoperoxidase staining as above and the
 tissue culture infectious dose (TCID50) calculated using
 Spearman–Karber method (Hamilton et al., 1977).
 Statistical analysis, calculation of D and Z values and the
 oral pig infectious dose
Statistical analysis, graphs and linear regression were
pared using GraphPad Prism 6. Dt values were
ulated from linear regression of virus titres versus
e at temperature t (D value = 1/slope). The tempera-
e change needed to change the D value by 90% (z values)
 95% conﬁdence intervals for each tissue were
ermined from the slopes of linear regression of log10
values (minutes) versus temperature. Differences
ween mean values were analysed by one-way ANOVA
h Tukey’s multiple comparison test.
Estimate of the dose required to infect 50% of pigs
culated via the oral dose, together with 95% conﬁdence
rvals (CI) was determined using the trimmed Spear-
n–Karber method (Hamilton et al., 1977, 1978).
 Determination of the pig oral infectious dose
Sixty-six, 10-week old Large White/Landrace cross male
s, which were free from antibodies to all pestiviruses,
re purchased from a local commercial supplier. Five
ups of six pigs were inoculated with serial ten-fold
tions of UK2000/7.1 and in a separate experiment six
ups of six pigs were inoculated with similar ten-fold
tions of Brescia. Pigs weights ranged between 12.8 kg
 24.5 kg and animals were allocated into groups such
t the mean weights and standard deviations were
4 kg (SD 0.1) or 19.0 kg (SD 0.1) for the UK2000/7.1 or
scia inoculated animals, respectively. Groups were
sed in separate rooms.
Corn-covered blister pack baits, kindly provided by IDT
logika GmbH, were ﬁlled with 1.5 ml of EMEM contain-
 the required doses of either UK2000/7.1 or Brescia and
 individually to pigs. The viral inocula were back-
ated on the day of inoculation on PK15 cells to conﬁrm
 actual dose of virus fed.
Temperatures and clinical signs were recorded daily
throughout the experiment using a clinical scoring scheme
as described previously (Everett et al., 2010). Blood and
nasal swabs were collected at 2–3-day intervals. Leucocyte
counts and viral RNA copy numbers were determined by
ﬂow cytometry and qRT-PCR, respectfully, as described
previously (Graham et al., 2012). Animals were euthanised
by administration of 20% pentobarbitol solution either at
the end of the experiment, 28–32 dpi, or when clinical
scores exceeded 12.
The project was approved by the Animal and Plant
Health Agency Ethics Review Panel. Procedures were in
accordance with the UK Animals (Scientiﬁc Procedures)
Act 1986, and conducted under project license permit
number PPL70_6559.
3. Results
3.1. Amount of virus in tissues forming major components of
pork products
To identify samples from animals infected with CSFV
with viral loads sufﬁcient to determine rates of CSFV
inactivation, the viral concentrations in muscle, fat, skin
and lymph node samples were obtained from separate
CSFV infection studies from pigs infected with moderately
(UK2000/7.1, CBR/93) or highly virulent (Brescia) CSFV
(Everett et al., 2010; Graham et al., 2012). As expected, high
levels of virus were present in lymph nodes: mean
105.5 TCID50/g, range 10
4.8–107.1 TCID50/g. The levels of
virus in fat and muscle were lower and no viable virus
could be detected in skin samples. The mean viral load in
fat was 104.3 TCID50/g with titres ranging from less than the
quantiﬁable limit of the assay (102.8 TCID50/g) to as high as
105.9 TCID50/g. Whilst virus could be detected in most
muscle samples, many of the animals tested had levels that
were either only just above or below the quantiﬁable limit
of the assay. However, one animal, that had clinical signs
not consistent with CSF shortly after inoculation and which
responded to antibiotic treatment (Graham et al., 2012),
had 105.1 TCID50 of virus per g of muscle tissue.
3.2. There is little or no difference in the thermal inactivation
rate of different genotypes of CSFV of different virulence
Differences in virus thermal stability between different
CSFV have been reported (Aynaud et al., 1972; Depner
et al., 1992; Weesendorp et al., 2008), although these
differences were not always statistically signiﬁcant. To
determine if there are differences between the thermal
stability of strains for which tissues from infected animals
were available, the three strains used in this study, from
three different genotypes of CSFV, were incubated in cell
culture media at the mid-range temperature of 50 8C and
the amount of virus remaining after different time
intervals was determined and D values calculated for that
temperature (D50). There was no signiﬁcant difference
(P = 0.48) in thermal stability between the strains at this
temperature. Mean D50 values and standard deviations
were 51.6 (SD 21.8), 61.5 (SD 17.2), and 75.8 (SD 32.1) min,
L. Cowan et al. / Veterinary Microbiology 176 (2015) 1–94for CSFV Brescia (Genotype 1.1), UK2000/7.1 (2.1), and
CBR/93 (3.3), respectively.
3.3. The thermal inactivation rate of CSFV in porcine tissues
varies dependent on the matrix
To determine the rate at which CSFV is inactivated in
tissues found in pork products, samples of fat, lymph node
and muscle were incubated at the four key temperatures
of 68 8C, 56 8C, 25 8C and 4 8C. EC legislation (European
Union, 2003) states that heating to a minimum tempera-
ture of 70 8C, which must be reached throughout the
meat, is effective at eliminating the risk to animal health
due to CSFV. Therefore 68 8C was selected to determine
the extent of virus survival if treatments do not reach the
required temperature. Similarly, 56 8C was selected as a
temperature that would inform the ability of virus to
survive in composted material that may contain meat
products which does not reach the desired composting
temperature of 60 8C. The remaining temperatures were
selected to inform on the survival of CSFV in pork
products at ambient and refrigerated temperatures.
Serum samples were also incubated to assess the stability
of CSFV in diagnostic samples and biological reagents. For
the majority of samples, triplicate experimental repeats
were completed and mean TCID50 at eight incubation
time points were obtained. For muscle tissues, only
samples from the single animal that had an underlying
infection had a sufﬁcient titre to determine inactivation
rates. Due to the limited quantities of muscle samples
from this animal, fewer replicate experiments were
completed. Some inactivation curves had a slightly
biphasic shape but the data were largely a reasonable
ﬁt for a linear model (median r2 = 0.85) and D values were
calculated from linear regression analysis (Table 1,
Supplementary Figs. S1–S4). At the highest temperature
(68 8C) there was no difference in virus inactivation rates
between the different tissue matrices except for fat
samples: The virus survived twice as long in fat as in the
other tissues (Fat vs LN or Serum: P < 0.01). At lower
temperatures, a substantial difference was observed
between matrices. At 56 8C a log10 reduction in the
amount of virus was achieved in lymph nodes, fat and
muscle within 3 min. However, in serum, virus survival
was signiﬁcantly longer compared to other tissues
(P < 0.001). In three of four replicate assays, D56 values
of about 30 min were obtained for serum. In the fourth
assays performed at this temperature, over 1.5 h were
required to achieve a 1 log10 reduction in the virus load.
This 4th experiment appears to be an outlier, although no
difference in the experimental parameters could be
identiﬁed. At ambient temperature (25 8C), virus survival
was similarly much longer in serum compared to lymph
node and fat. Interestingly, virus survival in muscle at
25 8C was also substantially greater than in lymph node or
fat (P < 0.05). A greater virus survival in muscle was also
observed at chilling temperature: a 1 log reduction
occurred within 1.1–2.8 weeks in lymph nodes and fat
whereas 4.7 or 6.5 weeks were required for a similar
reduction in muscle (P < 0.05).
Supplementary Figs. S1–S4 related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.
vetmic.2014.12.003.
3.4. Calculation of Z values
To enable interpolation of the virus inactivation rates at
different temperatures from those tested, the log10 D
values were plotted versus temperature for all tissues
(Fig. 1). Analysis of r2 values (>0.95) and runs tests
indicated the data do not signiﬁcantly deviate from
linearity and so Z values were calculated from linear
regression analysis (Table 2). The line equation of the linear
regression of D values and the Z values can be used to
predict D values at different temperatures. For example, it
can be calculated that the D60-value for CSFV in lymph
node, fat and muscle tissue will be 1.7 min, 1.5 min and
2.3 min, respectively. Conservative estimates of the D
value at different temperatures can be achieved using the
upper limit of the 95% conﬁdence interval so, for example,
a conservative estimate of the D60 value in lymph node
tissue would be 4.5 min. Similarly at 70 8C, the tempera-
ture that EU legislation indicates is sufﬁcient to eliminate
health risks linked to meat, the following D70 values and
conservative estimated based on the upper 95% conﬁdence
interval (in brackets) can be calculated: muscle 0.33
(19.2) min, fat 0.26 (2.1) min, lymph node 0.29 (0.89) min
and serum 0.76 (10.6) min.
Table 1
Mean decimal reduction values (D values) for inactivation of CSFV in tissues at key temperatures.
Sample D values (standard deviation)
68 8C (min) 56 8C (min) 25 8C (h) 4 8C (weeks)
Lymph node 0.47 (0.01) 2.38 (1.1) 32.24 (2.52) 2.22 (0.49)
Fat 1.15 (0.24) 2.99 (0.76)a 36.55 (13.80) 1.51 (0.39)
Muscle 0.41b 2.11b 148.01c(87.67) 5.6c (1.27)
Serum 0.53 (0.07) 48.38a (35.75) 219.92 (7.60) nd
Mean D values were determined from linear regression analysis of triplicate inactivation experiments. Only a limited quantity of material was available
from the one animal identiﬁed with high viral loads in muscle. A smaller number of replicate experiments where therefore used to determine the
inactivation rates in muscle.
a n = 4.
b n = 1.
c n = 2.
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her than for intranasal inoculations and independent of
in virulence
To establish the amount of virus required to initiate CSF
the oral route, groups of six animals were fed doses of
s ranging from 101 to 106 TCID50 of the moderately
lent UK2000/7.1 or the highly virulent Brescia. In the
2000/7.1 experiment, all the animals fed blister packs
taining 101–103 TCID50 remained healthy throughout
 experiment except for one animal which was eutha-
ed for welfare reasons at 11 dpi due to signs unrelated
to CSF. RT-PCRs on blood and nasal swab samples and
blood leucocyte levels in all animals in these three groups
indicated that none had become infected with CSFV
(Table 3). Viral RNA was ﬁrst detected at 4 or 6 dpi in
the blood of three of the six animals fed 104 TCID50 of
UK2000/7.1 (Fig. 2A). One of these animals developed
1. Linear regression analysis of log D values (minutes) versus temperature for CSFV in tissues. Values are mean D values for all tissue types. Error bars
esent standard deviation of the mean. Solid lines connect the data points. Dotted lines indicate the linear regression best ﬁt lines for which the line
ations are included.
le 2
lues for inactivation of CSFV in tissues.
mple Z value (8C) 95% conﬁdence interval (8C)
mph node 13.0 12.0–14.3
t 14.2 12.7–16.1
uscle 11.8 9.1–16.8
rum 10.3 8.8–12.4
 temperature change required to change the log10 D value by 1 for
 in different tissues was determined from the slope of linear
ession of log10 D values versus temperature. The 95% conﬁdence
Table 3
Number of pigs infected after ingestion of different doses of CSFV.
UK2000/7.1 Brescia
Dose
(TCID50)
Number of
pigs infected
(out of 6)
Dose
(TCID50)
Number of
pigs infected
(out of 6)
101.2 0 101.3 0
102.2 0 102.3 0
103.2 0 103.3 0
104.2 3 104.3 0
105.2 5 105.3 2
106.2 nt 106.3 6
Number of pigs designated to have been infected by ingestion of oral
inoculum.
Groups of pigs were fed 10-fold serial dilutions of the highly virulent
Brescia or moderately virulent UK2000/7.1 CSFV and infection by
inoculum versus contact infection determined due to the timing ofrvals were also determined from the best ﬁt line of linear regression
ysis.
onset of viraemia and clinical signs.
nt = not tested.
L. Cowan et al. / Veterinary Microbiology 176 (2015) 1–96clinical signs of CSF and was euthanized at 15 dpi. The
other two pigs had only mild signs, with clinical scores not
exceeding 6. RNA copy numbers in blood samples only
reached moderate levels, which decreased after 14 dpi.
Given the time between bait administration and onset of
clinical signs and viraemia, these three animals were
considered to have been infected directly through inges-
tion of the oral inoculum. Viral RNA was ﬁrst detected in
nasal swab samples from this group at 8 dpi, with high
levels detected in swabs from the animal that was
euthanized for ethical reasons. Viral RNA was only
detected in blood of the remaining three animals 6 days
later, at 14–16 dpi, and these animals were considered to
have become infected indirectly, through contact infection,
rather than directly from ingestion of the inoculum.
Similarly, in the group fed 105 TCID50 UK2000/7.1, ﬁve of
the six animals were designated to have been infected by
the inoculum due to viral RNA levels detected in the blood
from 6 dpi; the remaining animal only became viraemic
10 days after viral RNA was detected in nasal secretions
(Fig. 2B). Interestingly, the levels of RNA in blood decreased
in a high proportion of animals considered to have been
infected directly by the oral inoculum, indicating that
these animals were clearing the infection.
It was anticipated that, compared with moderately
virulent viruses, lower amounts of highly virulent strains
would be able to initiate infection. However, all animals
fed doses of 101–104 TCID50 of the highly virulent CSFV
Brescia remained healthy and no virus was detected in
blood, nasal swabs and no decrease in leucocyte numbers
was observed. Viral RNA was detected at 4 dpi in the
blood of two animals fed 105 TCID50 which were
euthanized at 5 and 6 dpi due to clinical signs of CSF
(Fig. 2C). Viral RNA was detected at 6 dpi in nasal swab
samples from one of these two animals. Detection of viral
RNA and development of clinical signs in the remaining
four animals in this group occurred in phases, with
animals being euthanized due to clinical disease on 12,
19, 24 and 26 dpi. It was concluded that only two animals
in this group became infected via the oral inoculum. All
animals fed 106 TCID50 developed CSF signs within 4 or
5 dpi (Fig. 2D).
The infectious dose that resulted in infection of 50% of
pigs via the oral route (oral PID50) for the two strains was
determined as 104.2 TCID50 (95% CI 10
3.6–105) for UK2000/
7.1 and 105.5 TCID50 (95% CI 10
5.1–105.8) for Brescia. The
difference in oral PID50 between the two strains is
signiﬁcant (P < 0.05)
A
B
C
D
Fig. 2. Discrimination of animals infected via ingestion of inoculum versus contact infection. Viral RNA detected in the blood of animals inoculated with the
two highest doses of either UK2000/7.1 or Brescia. Different lines and symbols represent the individual animals within each group of six. Arrows indicate
the day post inoculation that CSFV viral RNA was ﬁrst detected in nasal secretions. In the group inoculated with 105.3 TCID50 Brescia RNA was detected in
two nasal swab samples only (both indicated by arrow).
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Assessment of the risks of products from animals which
y be infected with exotic diseases requires estimation of
 likely pathogen load. Quantiﬁcation of the viable CSFV
issues from experimentally infected animals conﬁrmed
 viral loading is lower in tissues that form the majority
ork products (muscle and fat) than in lymphoid tissues,
ich have higher virus concentrations but constitute only
mall proportion of total carcass weight. The levels of
s detected in muscle and fat are consistent with studies
ich detected CSFV less frequently in striated muscle
pared to other tissues (Thur and Hofmann, 1998) and
vious attempts to titrate virus loads in fat and muscle
icated that levels are often close to or below the
ntiﬁable limit of cell culture assays (McKercher et al.,
7; Mebus et al., 1993; Wood et al., 1988). No viable
s could be detected in skin samples. However, other
dies have detected CSFV in skin (Kaden et al., 2007;
od et al., 1988) and so, although the levels are likely to
low, the risk due to CSFV may not be negligible in
ducts containing porcine skin.
Whilst a comprehensive quantiﬁcation of viral loads in
mals infected with CSFV of different virulence and at all
es of CSF disease was beyond the scope of this study,
 mean viral loadings reported here are representative of
els in tissues from most weaner pigs with acute CSF. The
h viral loads obtained in one animal with underlying
ase highlights that viral loads are inﬂuenced by the
lth status of an animal. For consideration of the worst
e scenario, conservative estimates can be made using
 upper range of values reported here.
In contrast to other studies, we did not detect a
iﬁcant difference in the stability in cell culture media
he three isolates tested. Notably, the greatest difference
thermal stability between isolates reported (Depner
al., 1992) was observed at pH3, whereas variation
ween strains at pH7, the pH use in this study, was
imal. The absence of signiﬁcant difference between the
ee isolates tested allowed use of material from animals
cted with these strains for investigation of thermal
ility in tissues. However, the pH of muscle tissues used
this study was 6.1 and so we cannot exclude the
sibility that small differences in thermal stability might
st at this slightly lower pH, at different temperatures or
ween other strains.
This study has generated data that can be used to
mate the length of time required to inactivate all virus
sent in a product. The data indicate that CSFV remains
ble for a considerable time under chilled conditions. For
mple, a product with a starting titre of 104 TCID50/g in
scle tissue would be predicted to contain viable virus
22 weeks at 4 8C, which is longer than products are
ly to be kept refrigerated.
Similarly, for an infected product containing a portion
at with a starting titre of 104 TCID50/g, it is predicted
t heating to 68 8C for 6 min could be required to
ctivate the viable virus within the fat portion. This
hlights that failure of a process to reach 70 8C
oughout the product, as required by EU legislation
2/99/EC (European Union, 2003) in order to eliminate
the risk of CSF due to introduction of products of animal
origin, could allow viable virus to remain. Indeed, even if
the target temperature of 70 8C is reached the extent that
all CSFV that could be present would be inactivated is
questionable. The legislation does not speciﬁy a time for
which the 70 8C target must be applied for, but estimation
of D70 values indicate that the target temperature would
have to be achieved for over 1 min to reduce material with
a titre of 104 TCID50/g to zero. Much longer periods would
be required if conservative estimates based on the upper
95% CI are applied. A reduction of the level of virus to zero
TCID50 may be insufﬁcient to give conﬁdence that the risk
of CSF is eliminated. For canned goods, a sterilising process
is one that achieves a 12-log reduction in the most
resistant microorganism. At 70 8C, a 12-log reduction
would require heating for 4 min (12 times the D value) for
muscle tissues. Council directive 2202/99/EC also lists
80 8C as an acceptable treatment to eliminate CSF. From
our data it can be estimated that the D80 value for muscle is
2.8 s, indicating that adopting this temperature as a
minimum for acceptable treatments would eliminate the
possibility for viable CSFV to remain. Alternatively, the
legislation could be revised to deﬁne a minimum time
required for treatments at 70 8C.
There was a signiﬁcant difference in virus stability in
the different tissue matrices which were more pronounced
at lower temperatures. Under ambient temperature
conditions, muscle with104 TCID50/g would theoretically
still contain viable virus for up to 24 days. Although
lymphoid tissue from the same CSFV infected animal will
have a higher virus titre than muscle tissues the virus is
less stable in this tissue type compared to muscle at 25 8C.
Therefore, if lyphoid tissue with a starting titre of, for
example, 106 TCID50 was also held at 25 8C, it would be
predicted that virus in this matrix would only remain
viable for up to 8 days. Faster inactivation rates for CSFV in
pig slurry compared to tissue culture media have been
reported by others (Botner and Belsham, 2012) highlight-
ing the importance of considering if available survival data
has been generated from a relavent matrix when estimat-
ing risk. The mechanisms behind matrix dependent
differences in inactivation rate are unclear. We speculate
that at higher temperatures the denaturing effect of heat
on viral proteins, particularly disruption of capsid, is less
affected by the matrix whereas, at lower temperatures, the
mechanism of virus inactivation may be inﬂuenced by the
activity of enzymes. For example, lipases that could result
in disruption of the viral envelope may be present in higher
levels in lymph node and fat matrices than muscle.
Hepatitis C virus, which, like CSFV, is an enveloped
member of the ﬂaviridae, is inactivated in milk by a lipase
dependent mechanism (Pfaender et al., 2013), most likely
due to the release of fatty acids which inactivate enveloped
viruses (Thormar et al., 1987).
At 56 8C, CSFV is inactivated rapidly in muscle, lymph
node and fat samples and our data give conﬁdence that
composting processes which require a temperature of
60 8C for 2 days, are more than adequate to inactivate CSFV.
However, in serum the virus is substantially more stable at
this temperature. Treatment of serum at 56 8C for 30 min,
which is used to inactivate complement prior to serological
L. Cowan et al. / Veterinary Microbiology 176 (2015) 1–98tests, will, at most, reduce viral titre by only one log10 and
so is insufﬁcient to inactivate all CSFV that could be present
and is not appropriate as a method to release serum
samples that may contain CSFV from biocontainment.
The generation of Z values allows estimations to be
made on virus survival in these tissues at other tempera-
tures. Such estimations are useful when no data exists at a
given temperature for a particular matrix. However, due
caution should be applied as the variation between actual
and estimated D values could have a substantial practical
impact. The results reported here indicate CSFV is more
stable at room temperatures in lymph node than has been
reported by others (Weesendorp et al., 2010), highlighting
the high level of variablity between studies and hence the
impact that slight variations in the conditions of a process
involving pork products could have. It should also be noted
that various differences exist between the samples from
experimental infections used in this study compared to
processed pork products. For example, the method of
slaughter, exangination and hanging/chilling of carcase
prior to butchering, processing of product such as curing
and packaging to maintain shelf life are likely to affect
virus stability.
The amount of a virus required to cause infection
varies according to the route. For porcine respiratory and
reproductive virus (PRRSV), the oral PID50 is estimated as
105.3 TCID50 whereas a lower value of 10
4 was estimated
for intranasal exposure (Hermann et al., 2005). Virulence
can also affect the dose required to instigate infection. For
example, a low intranasal dose of moderately virulent
CSFV failed to instigate infection whereas all animals
inoculated with a similar dose of highly virulent virus
became infected (Weesendorp et al., 2009a). We there-
fore determined the oral ID50 of both a virulent and
moderately virulent CSFV. Blister packs designed for oral
vaccination of wild boar were used to encourage
chewing, rather than swallowing, of the inoculum to
allow some contact with tissues in the mouth and tonsils,
rather than likely inactivation by the low pH in the
stomach. Whilst this route is not an exact representation
of what might happen if an animal were to eat an infected
pork product, it allowed inoculation of accurate dilution
of doses in a standard volume, which would not have
been possible by attempting to feed pigs with tissues
from infected donor animals. The dose required to infect
50% of pigs via this oral route was much higher than
via intranasal inoculation (Farez and Morley, 1997;
Weesendorp et al., 2009a). Although, dose response data
have not been published on oral live attenuated CSFV
vaccines administered using blister baits, our data are in
accordance with the stated dose require for oral
vaccination (Kaden et al., 2010).
Surprisingly, a slightly higher dose of the highly
virulent virus was required for infection than the
moderately virulent virus. It is unclear if this higher dose
represents a true difference between the two strains
tested, as the data are from a limited number of
experiments performed at different times. Whilst we
cannot exclude the possibility that other highly virulent
strains may instigate infection via ingestion at lower doses,
represent an increased risk of infection via the oral route
compared with moderately virulent viruses.
5. Conclusion
Our data provide information to estimate how much
CSFV may remain viable in a porcine product at different
temperatures and how much of a product would need to be
ingested to instigate infection in 50% of animals. Although
higher than previously stated, the amount required is still
present in a few grams of tissue from infected pigs and the
different stabilities between tissues indicates the impor-
tance of basing estimates on stability data generated in a
relevant matrix.
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